Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3
- PMID: 21697347
- DOI: 10.1099/vir.0.034322-0
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) encodes four viral interferon regulatory factors (vIRF-1-4). We investigated the mechanism and consequences of vIRF-2-mediated inhibition of interferon-response element signalling following type I interferon (IFN) induction. Western blot and electrophoretic mobility-shift assays identified the interferon-stimulated gene factor-3 (ISGF-3) components STAT1 and IRF-9 as the proximal targets of vIRF-2 activity. The biological significance of vIRF-2 inhibition of ISGF-3 was demonstrated by vIRF-2-mediated rescue of the replication of the IFN-sensitive virus encephalomyocarditis virus. This study provides both a mechanism and evidence for KSHV vIRF-2-mediated suppression of the consequences of type 1 IFN-induced signalling.
Similar articles
-
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.J Virol. 2011 May;85(9):4530-7. doi: 10.1128/JVI.02123-10. Epub 2011 Feb 23. J Virol. 2011. PMID: 21345951 Free PMC article.
-
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5.J Biol Chem. 2009 Mar 27;284(13):8525-38. doi: 10.1074/jbc.M809252200. Epub 2009 Jan 7. J Biol Chem. 2009. PMID: 19129183 Free PMC article.
-
Proximity Biotin Labeling Reveals Kaposi's Sarcoma-Associated Herpesvirus Interferon Regulatory Factor Networks.J Virol. 2021 Apr 12;95(9):e02049-20. doi: 10.1128/JVI.02049-20. Print 2021 Apr 12. J Virol. 2021. PMID: 33597212 Free PMC article.
-
Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.J Virol. 2011 Nov;85(21):10934-44. doi: 10.1128/JVI.00687-11. Epub 2011 Jul 20. J Virol. 2011. PMID: 21775463 Free PMC article. Review.
-
On the role of IRF in host defense.J Interferon Cytokine Res. 2002 Jan;22(1):59-71. doi: 10.1089/107999002753452665. J Interferon Cytokine Res. 2002. PMID: 11846976 Review.
Cited by
-
Aflatoxin B1 inhibits the type 1 interferon response pathway via STAT1 suggesting another mechanism of hepatocellular carcinoma.Infect Agent Cancer. 2017 Mar 20;12:17. doi: 10.1186/s13027-017-0127-8. eCollection 2017. Infect Agent Cancer. 2017. PMID: 28344639 Free PMC article.
-
STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling.PLoS Pathog. 2022 Jul 1;18(7):e1010676. doi: 10.1371/journal.ppat.1010676. eCollection 2022 Jul. PLoS Pathog. 2022. PMID: 35776779 Free PMC article.
-
Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses.J Immunol Res. 2019 Apr 4;2019:8685312. doi: 10.1155/2019/8685312. eCollection 2019. J Immunol Res. 2019. PMID: 31089479 Free PMC article. Review.
-
KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production.Biochem Biophys Res Commun. 2017 May 6;486(3):700-705. doi: 10.1016/j.bbrc.2017.03.101. Epub 2017 Mar 22. Biochem Biophys Res Commun. 2017. PMID: 28342865 Free PMC article.
-
Kaposi sarcoma herpesvirus pathogenesis.Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):20160275. doi: 10.1098/rstb.2016.0275. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28893942 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
